-
Gary Schiller, MD; University of California Los Angeles; 5Live #ASH21
2:21
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Aaron Gerds, MD, MS; Cleveland Clinic; 5Live #ASH21
6:51
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Srdan Verstovsek, MD, PhD; MD Anderson Cancer Center #BtC_ASCO21
14:44
Dr. Srdan Verstovsek reviews Recently Presented Data of Clinical Trials in Patients with MPNs.
-
Beyond the Congress Video Edits Susan O'Brien_recap_#BeyondASH21recap
3:44
-
Beyond the Congress Video Edits Nina Shah_recap_#BeyondASH21recap
4:20
-
Beyond the Congress Video Edits Kenneth Anderson_recap_#BeyondASH21recap
2:48
-
Beyond the Congress Video Edits Courtney DiNardo_recap_#BeyondASH21recap
4:12
-
Beyond the Congress Video Edits Sagar Lonial_recap_#BeyondASH21recap
5:33
-
Beyond the Congress Video Edits Brad Kahl_recap_#BeyondASH21recap
7:42
-
Beyond the Congress Video Edits John Leonard_recap_#BeyondASH21recap
5:15
-
Beyond the Congress Video Edits Sonali Smith_recap_#BeyondASH21recap
2:41
- Next Page
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company